View Alert
Versions:


Originator: CMO Messaging

 
From: Professor Stephen Powis

Issue date: Originally issued on 17-Mar-2020 20:25:47. This version was issued on 17-Mar-2020 20:25:47

Action by recipients:
  • NHS Regional Offices
  • NHS Foundation Trusts (England) - Medical Director
  • NHS Foundation Trusts (England) - Chief Executive
  • NHS Trusts (England) - Medical Director
  • NHS Trusts (England) - Chief Executive

Information to recipients:
  • Other contacts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • Social Care Providers (registered with CAS)
  • CMO Urgent Messages - Non-NHS Recipients on Public Health Link
  • Territorial CMOs in Northern Ireland, Scotland & Wales
  • Regional Directors of Public Health
  • Consultants in Communicable Diseases
  • CMO Urgent Messages - Recipients on Public Health Link
  • Director of Public Health
  • GP - Locum
  • NHS 111 and Out of hours providers
  • GP Practices
  • Out of hours contacts
  • Primary Care Networks

Action category: Important information for immediate action

Title: Novel Coronavirus - Anti-inflammatory medications

Broadcast content: This alert addresses recent concern about the use of non-steroidal anti-inflammatory medications (NSAIDs) in relation to Covid-19.

Additional information: NHS England Regional Offices: please cascade to Community Pharmacy, Dental, Optometry and any GP Practices not registered with CAS.

Alert reference: CEM/CMO/2020/010

Attachments:

Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency